1 nfant Aphakia Treatment Study, a randomized,
multi-center (
12) clinical trial comparing the treatment
2 cus-specific databases launched in 2001 by a
multi-center academic effort to provide timely informati
3 The
multi-center ASCUS-LSIL Triage Study has shown that HPV
4 ated deaths was obtained from the Salmeterol
Multi-center Asthma Research Trial (SMART).
5 ear-patient blood processing system within a
multi-center clinical study of the immune response to se
6 The design and conduct of a 9-month
multi-center clinical trial to evaluate the safety and e
7 In the Silent Cerebral Infarct
Multi-Center Clinical Trial, we sought to identify risk
8 double-blind, randomized, placebo-controlled
multi-center clinical trials (5 centers each) were condu
9 Randomized, placebo-controlled,
multi-center clinical trials of human TNF alpha inhibito
10 The PSP Appendix Trial is a prospective,
multi-center,
cohort study to assess the value of PSP in
11 GN: The PSP Appendix Trial is a prospective,
multi-center,
cohort study to assess the value of PSP in
12 Although increases in sample size across
multi-center cohorts will likely yield important new res
13 Through a
multi-center collaboration study, we here report six ind
14 Through an international
multi-center collaboration, 13 individuals from nine unr
15 Through a
multi-center collaboration, we identified six de novo ge
16 Through a
multi-center collaborative study based on a whole-exome
17 In this large,
multi-centered,
collaborative study, we performed statis
18 SMAD7 SNPs and colorectal cancer risk in the
multi-center Colon Cancer Family Registry.
19 A prospective,
multi-centered contrastive study is warranted to confirm
20 This parallel group, randomized,
multi-center,
controlled clinical trial involved 112 pat
21 This is a European
multi-center cross-sectional population-based study.
22 of 17,809 CHB patients were enrolled in this
multi-center cross-sectional study.
23 In this Phase 4,
multi-center,
double-blind, placebo-controlled trial, yo
24 We conducted a
multi-center,
double-blind, randomized, placebo-controll
25 Retrospective,
multi-center,
exploratory cohort study of ICU survivors
26 yielded excellent results when applied to a
multi-center external data set.
27 participants of the MIRAGE Study, an ongoing
multi-center family-based genetic epidemiology study of
28 the molecular etiology of HGSCs, we report a
multi-center integrated genomic analysis of advanced sta
29 Multi-center inter-observer agreement for plaque classif
30 We used data from a contemporary,
multi-center international registry of TA-AAD patients t
31 rmed a case-control study, nested within the
multi-center Lung Transplant Outcomes Group cohort.
32 This is a sub-study of the cross-sectional
multi-center "
Matching Registered Nurse Services with Ch
33 s in neoadjuvant chemotherapy use in a large
multi-center national database of patients with breast c
34 We performed a
multi-center,
parallel, single-blind study of 75 patient
35 We performed a
multi-center phase II trial investigating the safety and
36 ed small clinical trials compared with large
multi-center Phase III trials that are more likely to be
37 This study was a randomized,
multi-center,
placebo-controlled, double-blind trial.
38 An open-label,
multi-center,
prospective clinical trial in two subgroup
39 These
multi-center randomized control trials suggest that the
40 Caries Trial was a three-year, double-blind,
multi-center,
randomized clinical trial that evaluated t
41 This study is a prospective,
multi-center,
randomized investigation performed in the
42 The final results of this
multi-center,
randomized study of two forms of cyclospor
43 The aims of the present
multi-center,
randomized, controlled clinical trial were
44 METHODS.: This phase 2,
multi-center,
randomized, double-blind, placebo-controll
45 from 113 adults with NASH participating in a
multi-center,
randomized, double-masked, placebo-control
46 the execution of high quality, prospective,
multi-center,
randomized-controlled trials are restricte
47 s phenomenon has been reported in real-world
multi-center registries as a rare event.
48 rates of patients enrolled in a prospective,
multi-center Registry of acute myocardial infarction (MI
49 successfully developed using a contemporary
multi-center registry.
50 on (PCI) procedures using data from a large,
multi-center registry.
51 graft survival remains unknown, and further
multi-center reports are needed.
52 ed method is illustrated on a dataset from a
multi-center research study of inflammation and response
53 This is a
multi-center,
retrospective evaluation of CRT in 103 pat
54 We performed a
multi-center,
retrospective, observational study using a
55 This
multi-center single-blind study compared clinical outcom
56 riodontal treatment, whereas the large-scale
multi-center studies did not demonstrate efficacy.
57 Therefore, it is necessary to conduct large,
multi-center studies to determine the methodology, indic
58 uding the emergence of increasing numbers of
multi-center studies, comparative assessments between pr
59 OH), and scaling and root planing (SRP) in 2
multi-center studies.
60 In the current
multi-center study (four centers), we used proton magnet
61 trols matched for age from the FECD Genetics
Multi-Center Study (n = 2044 subjects) were examined.
62 This
multi-center study evaluated the potential for sensitiza
63 Preliminary results from a large
multi-center study have cast doubt on the benefit of the
64 A
multi-center study is one conducted simultaneously in se
65 In a
multi-center study of patients with acute MI undergoing
66 e scrutiny as technological enhancements and
multi-center study results are reported.
67 (Prospective, Randomized, Single-Blind, U.S.
Multi-Center Study to Evaluate Treatment of Obstructive
68 The purpose of this prospective
multi-center study was to evaluate a resorbable barrier
69 In this
multi-center study we compared SNP frequencies in 364 pe
70 In a
multi-center study, 42 patients with AMI (<6 h from symp
71 in this prospective, randomized-controlled,
multi-center study, in which a total of 97 patients were
72 ith nonalcoholic steatohepatitis (NASH) in a
multi-center study, using central histology as reference
73 were enrolled in a prospective, open-label,
multi-center study.
74 ell, Hedegaard et al. report a comprehensive
multi-center transcriptional analysis of non-muscle inva
75 A
multi-center trial (ARUBA) has been proposed to test the
76 to advanced periodontitis were enrolled in a
multi-center trial and randomized to 1 of 3 treatment ar
77 ced chronic periodontitis were enrolled in a
multi-center trial and randomized to either: 1) SRP alon
78 ospective, double-blind, placebo-controlled,
multi-center trial involved 297 high-risk (urgent surger
79 double-blind, placebo-controlled, phase III
multi-center trial of oral myelin in 515 relapsing-remit
80 possibility of a gender effect, this phase 2
multi-center trial was undertaken to determine whether T
81 The study is a
multi-center trial with an "all-comers" design, randomiz
82 osseous defects in a controlled, monitored,
multi-center trial.
83 osseous defects in a controlled, monitored,
multi-center trial.
84 or no agent (VC) was evaluated in a 9-month
multi-center trial.
85 n medical disorders, randomized, controlled,
multi-center trials are needed to assess the safety and
86 Further prospective data from
multi-center trials are required.
87 Previous
multi-center trials demonstrated the efficacy of a biode
88 ne single center inter-observer variability;
multi-center variability was determined by comparison wi
89 Here, in a United States-based,
multi-center,
yoked case-control study with standardized